(Q34558531)

3 August 2017

1 reference

title

What can we learn from clinical trials of anticonvulsant drugs in epilepsy? (English)

1 reference

3 August 2017

1

Emilio Perucca

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

published in

European Journal of Pain

1 reference

3 August 2017

volume

6 Suppl A

1 reference

3 August 2017

page(s)

35-44

1 reference

Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Oxcarbazepine add-on for drug-resistant partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

New antiepileptic drugs: comparison of key clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

The new antiepileptic drugs: pharmacological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

The two-period cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Therapeutic-class wars--drug promotion in a competitive marketplace

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Evaluation of drug treatment outcome in epilepsy: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Antiepileptic drugs as a cause of worsening seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Assessing risk to benefit ratio in antiepileptic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Dezinamide for partial seizures: results of an n-of-1 design trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Transaminase elevation on placebo during phase I trials: prevalence and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

The new generation of antiepileptic drugs: advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Hazards of inference: the active control investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

The value of the number-needed-to-treat method in antiepileptic drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Innovative monotherapy trial designs for the assessment of antiepileptic drugs: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Lamotrigine in treatment of 120 children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Validation of the phenomenon of regression of seizure frequency in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0320

21 January 2018

Identifiers

DOI

10.1053/EUJP.2001.0320

1 reference

3 August 2017

1 reference